Body mass index and risk of breast cancer: A nonlinear dose-response meta-analysis of prospective studies

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Xia, Xiaoping ^a   Chen, Wei ^b   Li, Jiaoyuan ^b   Chen, Xueqin ^b   Rui, Rui ^b   Liu, Cheng ^b   Sun, Yu ^b   Liu, Li ^d   Gong, Jing ^b   Yuan, Peng ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CANCER HOSPITAL   (China)

^d GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; BREAST NEOPLASMS; COMPLICATION; FEMALE; HUMAN; META ANALYSIS; OBESITY; PREMENOPAUSE; PROSPECTIVE STUDY; RISK FACTOR;

BODY MASS INDEX; BREAST NEOPLASMS; FEMALE; HUMANS; OBESITY; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84933054523     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07480     Document Type: Article

References (51)

1. Carmichael, A. R. & Bates, T. Obesity and breast cancer: a review of the literature. Breast 13, 85-92 (2004).
2. Flegal, K. M., Carroll, M. D., Ogden, C. L. & Curtin, L. R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303, 235-241 (2010).
3. Wu, Y. F. et al. The current prevalence status of body overweight and obesity in China: data from the China National Nutrition and Health Survey. Zhonghua Yu Fang Yi Xue Za Zhi 39, 316-320 (2005).
4. Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569-578 (2008).
5. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
6. Suzuki, R., Rylander-Rudqvist, T., Ye, W., Saji, S. & Wolk, A. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study. Int J Cancer 119, 1683-1689 (2006).
7. Kawai, M. et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Brit J Cancer 103, 1443-1447 (2010).
8. Sweeney, C., Blair, C. K., Anderson, K. E., Lazovich, D. & Folsom, A. R. Risk factors for breast cancer in elderly women. Am J Epidemiol 160, 868-875 (2004).
9. Michels, K. B., Terry, K. L. & Willett, W. C. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 166, 2395-2402 (2006).
10. Tehard, B. & Clavel-Chapelon, F. Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obesity (Lond) 30, 156-163 (2006).
11. Kaaks, R. et al. Breast-cancer incidence in relation to height, weight and body-fat distribution in the Dutch DOM cohort. Int J Cancer 76, 647-651 (1998).
12. Bianchini, F., Kaaks, R. & Vainio, H. Weight control and physical activity in cancer prevention. Obes Rev 3, 5-8 (2002).
13. Ursin, G., Longnecker, M. P., Haile, R. W. & Greenland, S. Ameta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6, 137-141 (1995).
14. Suzuki, R., Orsini, N., Saji, S., Key, T. J. & Wolk, A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status--a metaanalysis. Int J Cancer 124, 698-712 (2009).
15. Galanis, D. J., Kolonel, L. N., Lee, J. & LeMarchand, L. Anthropometric predictors of breast cancer incidence and survival in amulti-ethnic cohort of female residents of Hawaii, United States. Cancer Cause Control 9, 217-224 (1998).
16. Sonnenschein, E. et al. Body fat distribution and obesity in pre- and postmenopausal breast cancer. Int J Epidemiol 28, 1026-1031 (1999).
17. Manjer, J., Kaaks, R., Riboli, E. & Berglund, G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur J Cancer Prev 10, 33-42 (2001).
18. Weiderpass, E. et al. A prospective study of body size in different periods of life and risk of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 13, 1121-1127 (2004).
19. Wada, K. et al. Body mass index and breast cancer risk in Japan: a pooled analysis of eight population-based cohort studies. Ann Oncol 25, 519-524 (2014).
20. Li, H. L., Gao, Y. T., Li, Q. & Liu, D. K. Anthropometry and female breast cancer: a prospective cohort study in urban Shanghai. Zhonghua Liu Xing Bing Xue Za Zhi 27, 488-493 (2006).
21. Palmer, J. R., Adams-Campbell, L. L., Boggs, D. A., Wise, L. A. & Rosenberg, L. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev 16, 1795-1802 (2007).
22. Manders, P. et al. Body weight and risk of breast cancer in BRCA1/2 mutation carriers. Breast Cancer Res Tr 126, 193-202 (2011).
23. Cecchini, R. S. et al. Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prev Res (Phila) 5, 583-592 (2012).
24. van den Brandt, P. A., Dirx, M. J., Ronckers, C. M., van den Hoogen, P. & Goldbohm, R. A. Height, weight weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study. Cancer Cause Control 8, 39-47 (1997).
25. Mellemkjaer, L. et al. Body composition and breast cancer in postmenopausal women: a Danish prospective cohort study. Obesity (Silver Spring) 14, 1854-1862 (2006).
26. Song, Y. M., Sung, J. & Ha, M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 26, 3395-3402 (2008).
27. Kerlikowske, K. et al. Obesity, mammography use and accuracy, and advanced breast cancer risk. J Natl Cancer Inst 100, 1724-1733 (2008).
28. Lacey, J. V., Jr. et al. Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort. BMC Cancer 9, 84 (2009).
29. Phipps, A. I. et al. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev 20, 454-463 (2011).
30. Opdahl, S., Alsaker, M. D., Janszky, I., Romundstad, P. R. & Vatten, L. J. Joint effects of nulliparity and other breast cancer risk factors. Brit J Cancer 105, 731-736 (2011).
31. Canchola, A. J. et al. Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Cause Control 23, 473-485 (2012).
32. Gaudet, M. M. et al.Waist circumference, body mass index, and postmenopausal breast cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. Cancer Cause Control 25, 737-745 (2014).
33. Calle, E. E. & Kaaks, R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4, 579-591 (2004).
34. Sherman, B., Wallace, R., Bean, J. & Schlabaugh, L. Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk. J Clin Endocrinol Metab 52, 488-493 (1981).
35. Siiteri, P. K. et al. The serum transport of steroid hormones. Recent Prog Horm Res 38, 457-510 (1982).
36. Cheraghi, Z., Poorolajal, J., Hashem, T., Esmailnasab, N. & Doosti Irani, A. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One 7, e51446 (2012).
37. Amadou, A. et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev 14, 665-678 (2013).
38. Pischon, T. et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98, 920-931 (2006).
39. Borkan, G. A., Hults, D. E., Gerzof, S. G., Robbins, A. H. & Silbert, C. K. Age changes in body composition revealed by computed tomography. J Gerontol 38, 673-677 (1983).
40. Frayling, T. M. et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894 (2007).
41. Chen, W. et al. The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and ameta-analysis. Breast Cancer Res Tr 136, 847-857 (2012).
42. Chen, W. et al. Risk of GWAS-identified genetic variants for breast cancer in a Chinese population: a multiple interaction analysis. Breast Cancer Res Tr 142, 637-644 (2013).
43. Discacciati, A., Orsini, N. & Wolk, A. Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies. Ann Oncol 23, 1665-1671 (2012).
44. Harrell, F. E., Jr., Lee, K. L. & Pollock, B. G. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80, 1198-1202 (1988).
45. Orsini, N., Bellocco, R. & Greenland, S. Generalized least squares for trend estimation of summarized dose-response data. The stata journal 6, 40-57 (2006).
46. Larsson, S. C. & Orsini, N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol 174, 993-1001 (2011).
47. Zhu, B., Zou, L., Qi, L., Zhong, R. & Miao, X. Allium Vegetables and Garlic Supplements Do Not Reduce Risk of Colorectal Cancer, Based on Meta-analysis of Prospective Studies. Clin Gastroenterol Hepatol. DOI: 10.1016/ j.cgh.2014.03.019 (2014).
48. Orsini, N. & Greenland, S. A procedure to tabulate and plot results after flexible modeling of a quantitative covariate. The stata journal 11, 1-29 (2011).
49. Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539-1558 (2002).
50. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin Trials 7, 177-188 (1986).
51. Egger, M., Davey Smith, G., Schneider, M. & Minder, C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634 (1997).